Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Extracorporeal Shock Wave Therapy in Enhancing Plantar Sensitivity and Postural Stability in Multiple Sclerosis: A Quantitative Gait and Sensory Analysis

NCT07514104 is registered in ClinicalTrials.gov with Furkan Bilek as lead sponsor.

NCT NCT07514104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Extracorporeal Shock Wave Therapy in Enhancing Plantar Sensitivity and Postural Stability in Multiple Sclerosis: A Quantitative Gait and Sensory Analysis
Lead sponsor
Furkan Bilek
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2021
Completion date
October 15, 2025
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, multiple sclerosis (ms) - relapsing-remitting, sensorimotor gait disorder